Nintabid 150 Capsule is primarily used in the treatment of chronic, progressive interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD). Classified as a kinase inhibitor, this prescription medication works to slow the progression of these conditions by blocking specific growth factor receptors involved in the scarring and thickening of lung tissues. By doing so, it helps to slow the decline in lung function and improve the overall prognosis for adults suffering from these severe respiratory disorders.
50.1% CHEAPER

































































